Home/Filings/4/0000899243-17-019280
4//SEC Filing

Tomlin Stephen Lawrence 4

Accession 0000899243-17-019280

CIK 0001370053other

Filed

Jul 27, 8:00 PM ET

Accepted

Jul 28, 3:52 PM ET

Size

13.6 KB

Accession

0000899243-17-019280

Insider Transaction Report

Form 4
Period: 2017-07-26
Transactions
  • Sale

    Common Stock

    2017-07-26$24.35/sh37,040$901,9240 total(indirect: See footnote)
  • Other

    Common Stock

    2017-07-26399,9871,636,945 total(indirect: See footnote)
  • Other

    Common Stock

    2017-07-26+37,04037,040 total(indirect: See footnote)
Kinsella Kevin J
10% OwnerOther
Transactions
  • Other

    Common Stock

    2017-07-26399,9871,636,945 total(indirect: See footnote)
  • Sale

    Common Stock

    2017-07-26$24.35/sh37,040$901,9240 total(indirect: See footnote)
  • Other

    Common Stock

    2017-07-26+37,04037,040 total(indirect: See footnote)
Transactions
  • Other

    Common Stock

    2017-07-26+37,04037,040 total(indirect: See footnote)
  • Sale

    Common Stock

    2017-07-26$24.35/sh37,040$901,9240 total(indirect: See footnote)
  • Other

    Common Stock

    2017-07-26399,9871,636,945 total(indirect: See footnote)
Transactions
  • Sale

    Common Stock

    2017-07-26$24.35/sh37,040$901,9240 total(indirect: See footnote)
  • Other

    Common Stock

    2017-07-26399,9871,636,945 total(indirect: See footnote)
  • Other

    Common Stock

    2017-07-26+37,04037,040 total(indirect: See footnote)
Footnotes (3)
  • [F1]Represents a pro-rata in-kind distribution of Common Stock by Avalon Ventures VII, L.P. effected on July 26, 2017 without consideration to its limited partners and to its general partner, Avalon Ventures VII GP, LLC.
  • [F2]Represents the receipt by Avalon Ventures VII GP, LLC, the general partner of Avalon Ventures VII, L.P., of its pro-rata portion of the in-kind distribution described in footnote 1.
  • [F3]Represents the open-market sale by Avalon Ventures VII GP, LLC, the general partner of Avalon Ventures VII, L.P., of the Common Stock received as a result of the in-kind distribution described in footnote 1.

Issuer

ANAPTYSBIO INC

CIK 0001370053

Entity typeother

Related Parties

1
  • filerCIK 0001695652

Filing Metadata

Form type
4
Filed
Jul 27, 8:00 PM ET
Accepted
Jul 28, 3:52 PM ET
Size
13.6 KB